( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
24372.19
23401.52
22608.6
21031.83
Total Expenditure
19548.59
18639.79
18228.77
17146.15
PBIDT (Excl OI)
4823.6
4761.73
4379.83
3885.68
Other Income
178.54
152.29
185.34
106.75
Operating Profit
5002.14
4914.02
4565.17
3992.43
Interest
1035.38
1057.07
1106.89
1166.48
Exceptional Items
-337.04
NA
NA
NA
PBDT
3629.72
3856.95
3458.28
2825.95
Depreciation
2484.42
2303.05
2201.76
2137.16
Profit Before Tax
1145.3
1553.9
1256.52
688.79
Tax
423.73
478.58
316.59
194.02
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
721.56
1075.32
939.92
494.77
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
721.56
1922.27
911.35
486.89
Minority Interest
-19.8
-85.65
-25.81
-13.25
Shares of Associates
7.26
23.69
32.01
6.41
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
709.03
1860.31
917.56
480.05
Equity Capital
1319.69
1319.69
1319.69
1319.69
Calculated EPS
1.07
2.81
1.39
0.72
Calculated EPS (Annualised)
4.29
11.27
5.56
2.91
No of Public Share Holdings
394092715
394092715
394092715
383112715
% of Public Share Holdings
59.73
59.73
59.73
58.06
PBIDTM% (Excl OI)
19.79
20.34
19.37
18.47
PBIDTM%
20.52
20.99
20.19
18.98
PBDTM%
14.89
16.48
15.29
13.43